Literature DB >> 10891897

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

A Jaretzki1, R J Barohn, R M Ernstoff, H J Kaminski, J C Keesey, A S Penn, D B Sanders.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10891897     DOI： 10.1212/wnl.55.1.16

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  262 in total

1.  Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.

Authors:  D Lashley; J Palace; S Jayawant; S Robb; D Beeson
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

2.  Pilot trial of albuterol in spinal muscular atrophy.

Authors:  Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

3.  Myasthenic crisis after the cessation of FK506 in a patient with myasthenia gravis.

Authors:  Tetsuro Konishi; Mitsuru Sanada; Kazuya Takehana
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

4.  Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patients.

Authors:  Chang Young Lee; Dae Joon Kim; Jin Gu Lee; In Kyu Park; Mi Kyung Bae; Kyung Young Chung
Journal:  Surg Endosc       Date:  2010-08-19       Impact factor: 4.584

Review 5.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

7.  Rituximab in Refractory Myasthenia Gravis: Experience in a Single Healthcare Center in Mexico.

Authors:  Juan Carlos López-Hernández; Javier A Galnares-Olalde; Enrique Gómez-Figueroa; Adib Jorge de Sarachaga; Edwin Steven Vargas-Cañas
Journal:  Cureus       Date:  2021-02-08

8.  High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.

Authors:  Raffi Topakian; Fritz Zimprich; Stephan Iglseder; Norbert Embacher; Michael Guger; Karl Stieglbauer; Dieter Langenscheidt; Jakob Rath; Stefan Quasthoff; Philipp Simschitz; Julia Wanschitz; David Windisch; Petra Müller; Dierk Oel; Günther Schustereder; Stefan Einsiedler; Christian Eggers; Wolfgang Löscher
Journal:  J Neurol       Date:  2019-01-16       Impact factor: 4.849

9.  The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis.

Authors:  Jenn-Yu Wu; Ping-Hung Kuo; Pi-Chuan Fan; Huey-Dong Wu; Fuh-Yuan Shih; Pan-Chyr Yang
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

10.  Neuropsychological assessment in myasthenia gravis.

Authors:  Emilia J Sitek; Małgorzata M Bilińska; Dariusz Wieczorek; Walenty M Nyka
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.